Literature DB >> 16185857

Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins.

J Szejtli1, L Szente.   

Abstract

The bitter taste of drugs, food components, and any other substances which get in the mouth as dissolved in an aqueous solution, or in the saliva, can be strongly reduced or fully eliminated, if the bitter component forms an inclusion complex with an appropriate cyclodextrin (CD). The value of the complex association constant (determined by the structure of the bitter 'guest' molecule and the size and eventual substitution of the 'host' CD molecule), the temperature and the host/guest ratio determine the extent of complexation of the guest molecule (percentage of complexation) at the equilibrium. The K(ass) for most drug/CD complexes at 36 degrees C buccal cavity temperature is between 10(2) and 10(4) mol-1. If the unit dose (of a sublingual or chewing tablet, chewing gum) with a bitter drug (molecular weight of about 150, forming a 1:1 complex with betaCD) is approximately 10mg then the betaCD can be taken in a 5- or even 10-fold molar excess. Under such conditions more than 99% of the bitter drug is complexed, and because complexed molecules cannot react with the taste buds in the buccal cavity no bitter taste is perceived. Frequently, preparation of the drug/CD complex is not necessary, because the betaCD is present in a large excess, dissolved very quickly in the saliva and results in a saturated CD solution. Therefore, the complexation of the bitter drug is completed very rapidly. Only dissolved substances have taste and only CD complexable drug molecules can become debittered by CDs. Bitter, astringent components of foods (e.g. soya), beverages (e.g. naringin in citrus fruit juice, or chlorogenic acid and polyphenols in coffee) cigarette smoke (nicotine) also can be complexed and their taste reduced or fully eliminated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185857     DOI: 10.1016/j.ejpb.2005.05.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  33 in total

1.  Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate.

Authors:  Punit P Shah; Rajashree C Mashru
Journal:  AAPS PharmSciTech       Date:  2008-09-03       Impact factor: 3.246

2.  Taste perception of cyclic oligosaccharides: α, β, and γ cyclodextrins.

Authors:  Laura E Martin; Juyun Lim
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 3.160

3.  Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.

Authors:  Sateeshkumar Sathigari; Gurkishan Chadha; Y-H Phillip Lee; Nydeia Wright; Daniel L Parsons; Vijay K Rangari; Oladiran Fasina; R Jayachandra Babu
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

4.  Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking.

Authors:  Punit P Shah; Rajashree C Mashru; Yogesh M Rane; Arti Thakkar
Journal:  AAPS PharmSciTech       Date:  2008-02-20       Impact factor: 3.246

5.  Development of satranidazole mucoadhesive gel for the treatment of periodontitis.

Authors:  K Bansal; M K Rawat; A Jain; A Rajput; T P Chaturvedi; S Singh
Journal:  AAPS PharmSciTech       Date:  2009-05-29       Impact factor: 3.246

6.  Taste masking by spray-drying technique.

Authors:  Divyakumar Bora; Priyanka Borude; Kiran Bhise
Journal:  AAPS PharmSciTech       Date:  2008-11-19       Impact factor: 3.246

Review 7.  Physical approaches to masking bitter taste: lessons from food and pharmaceuticals.

Authors:  John N Coupland; John E Hayes
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

8.  An in vitro comparison of microdialysis relative recovery of Met- and Leu-enkephalin using cyclodextrins and antibodies as affinity agents.

Authors:  Heidi J Fletcher; Julie A Stenken
Journal:  Anal Chim Acta       Date:  2008-05-21       Impact factor: 6.558

9.  Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.

Authors:  Xuelian Hu; Yingbo Li; Engjuan Zhang; Xianzhu Wang; Mao Xing; Qian Wang; Jian Lei; Hua Huang
Journal:  AAPS PharmSciTech       Date:  2012-11-22       Impact factor: 3.246

Review 10.  Engineering of cyclodextrin glucanotransferases and the impact for biotechnological applications.

Authors:  Hans Leemhuis; Ronan M Kelly; Lubbert Dijkhuizen
Journal:  Appl Microbiol Biotechnol       Date:  2009-09-18       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.